Lu-177-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study Journal Articles Refereed uri icon

Overview

Published in

  • Lancet Oncology

Time

Date/time value

  • 2018

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(18)30198-0

Additional Document Info

Parent Title

  • LANCET ONCOLOGY

Volume

  • 19

Issue

  • 6

Publisher

  • Lancet